<?xml version='1.0' encoding='utf-8'?>
<document id="10688631"><sentence text="Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver."><entity charOffset="51-60" id="DDI-PubMed.10688631.s1.e0" text="midazolam" /><entity charOffset="64-76" id="DDI-PubMed.10688631.s1.e1" text="erythromycin" /><entity charOffset="78-87" id="DDI-PubMed.10688631.s1.e2" text="diltiazem" /><entity charOffset="93-102" id="DDI-PubMed.10688631.s1.e3" text="verapamil" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e0" e2="DDI-PubMed.10688631.s1.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e0" e2="DDI-PubMed.10688631.s1.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e0" e2="DDI-PubMed.10688631.s1.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e0" e2="DDI-PubMed.10688631.s1.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e1" e2="DDI-PubMed.10688631.s1.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e1" e2="DDI-PubMed.10688631.s1.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e1" e2="DDI-PubMed.10688631.s1.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e2" e2="DDI-PubMed.10688631.s1.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s1.e2" e2="DDI-PubMed.10688631.s1.e3" /></sentence><sentence text="To evaluate the degree of drug-drug interaction concerning metabolic inhibition in the liver quantitatively, we tried to predict the plasma concentration increasing ratio (R) of midazolam (MDZ) by erythromycin (EM), diltiazem (DLZ), or verapamil (VER) in rats"><entity charOffset="178-187" id="DDI-PubMed.10688631.s2.e0" text="midazolam" /><entity charOffset="189-192" id="DDI-PubMed.10688631.s2.e1" text="MDZ" /><entity charOffset="197-209" id="DDI-PubMed.10688631.s2.e2" text="erythromycin" /><entity charOffset="211-213" id="DDI-PubMed.10688631.s2.e3" text="EM" /><entity charOffset="216-225" id="DDI-PubMed.10688631.s2.e4" text="diltiazem" /><entity charOffset="227-230" id="DDI-PubMed.10688631.s2.e5" text="DLZ" /><entity charOffset="236-245" id="DDI-PubMed.10688631.s2.e6" text="verapamil" /><entity charOffset="247-250" id="DDI-PubMed.10688631.s2.e7" text="VER" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e0" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e1" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e2" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e3" e2="DDI-PubMed.10688631.s2.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e3" e2="DDI-PubMed.10688631.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e3" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e3" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e3" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e4" e2="DDI-PubMed.10688631.s2.e4" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e4" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e4" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e4" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e5" e2="DDI-PubMed.10688631.s2.e5" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e5" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e5" e2="DDI-PubMed.10688631.s2.e7" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e6" e2="DDI-PubMed.10688631.s2.e6" /><pair ddi="false" e1="DDI-PubMed.10688631.s2.e6" e2="DDI-PubMed.10688631.s2.e7" /></sentence><sentence text=" MDZ was administered through the portal vein at the steady state of plasma concentration of these inhibitors"><entity charOffset="1-3" id="DDI-PubMed.10688631.s3.e0" text="MDZ" /></sentence><sentence text=" The R values in the area under the plasma concentration curve of MDZ in the presence of EM, DLZ, and VER were 2"><entity charOffset="66-68" id="DDI-PubMed.10688631.s4.e0" text="MDZ" /><entity charOffset="89-91" id="DDI-PubMed.10688631.s4.e1" text="EM" /><entity charOffset="93-95" id="DDI-PubMed.10688631.s4.e2" text="DLZ" /><entity charOffset="102-104" id="DDI-PubMed.10688631.s4.e3" text="VER" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e0" e2="DDI-PubMed.10688631.s4.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e0" e2="DDI-PubMed.10688631.s4.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e0" e2="DDI-PubMed.10688631.s4.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e0" e2="DDI-PubMed.10688631.s4.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e1" e2="DDI-PubMed.10688631.s4.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e1" e2="DDI-PubMed.10688631.s4.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e1" e2="DDI-PubMed.10688631.s4.e3" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e2" e2="DDI-PubMed.10688631.s4.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s4.e2" e2="DDI-PubMed.10688631.s4.e3" /></sentence><sentence text="02, 1" /><sentence text="64, and 1" /><sentence text="30, respectively" /><sentence text=" The liver to plasma unbound concentration ratios of EM, DLZ, and VER at the steady state after infusion were 20"><entity charOffset="53-55" id="DDI-PubMed.10688631.s8.e0" text="EM" /><entity charOffset="57-59" id="DDI-PubMed.10688631.s8.e1" text="DLZ" /><entity charOffset="66-68" id="DDI-PubMed.10688631.s8.e2" text="VER" /><pair ddi="false" e1="DDI-PubMed.10688631.s8.e0" e2="DDI-PubMed.10688631.s8.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s8.e0" e2="DDI-PubMed.10688631.s8.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s8.e0" e2="DDI-PubMed.10688631.s8.e2" /><pair ddi="false" e1="DDI-PubMed.10688631.s8.e1" e2="DDI-PubMed.10688631.s8.e1" /><pair ddi="false" e1="DDI-PubMed.10688631.s8.e1" e2="DDI-PubMed.10688631.s8.e2" /></sentence><sentence text="8, 1" /><sentence text="02, and 3" /><sentence text="01, respectively, suggesting concentrative uptake of EM and VER into the liver"><entity charOffset="53-55" id="DDI-PubMed.10688631.s11.e0" text="EM" /><entity charOffset="60-62" id="DDI-PubMed.10688631.s11.e1" text="VER" /><pair ddi="false" e1="DDI-PubMed.10688631.s11.e0" e2="DDI-PubMed.10688631.s11.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s11.e0" e2="DDI-PubMed.10688631.s11.e1" /></sentence><sentence text=" The predicted R value in the presence of EM calculated by use of plasma unbound concentration was 1"><entity charOffset="42-44" id="DDI-PubMed.10688631.s12.e0" text="EM" /></sentence><sentence text="03, whereas the value calculated with liver unbound concentration was 1" /><sentence text="61, which was very close to the observed value" /><sentence text=" These findings indicated the need to consider the concentrative uptake of inhibitors into the liver for the quantitative prediction of metabolic inhibition" /><sentence text=" However, the predicted values in the presence of DLZ or VER calculated by use of liver unbound concentration were still underestimated"><entity charOffset="50-51" id="DDI-PubMed.10688631.s16.e0" text="DLZ" /><entity charOffset="57-58" id="DDI-PubMed.10688631.s16.e1" text="VER" /><pair ddi="false" e1="DDI-PubMed.10688631.s16.e0" e2="DDI-PubMed.10688631.s16.e0" /><pair ddi="false" e1="DDI-PubMed.10688631.s16.e0" e2="DDI-PubMed.10688631.s16.e1" /></sentence><sentence text=" This result may be due to the metabolic inhibition by the metabolites of both inhibitors" /><sentence text=" Therefore, when predicting the degree of metabolic inhibition quantitatively, the inhibitory effect by coadministered drugs and the disposition of these metabolites in the liver must also be considered" /><sentence text="" /></document>